Results Six of nine patients with bacterial keratitis and three of six patients with fungal keratitis resolved following CXL treatment. Patients with deep stromal keratitis or endothelial plaque ...

resulting in fluid collection with overlying bullae formation and stromal melting. A 45-year-old patient presented with stage II of diffuse lamellar keratitis on the first day after laser-assisted ...

The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory ...

AIM To review the clinical characteristics, diagnosis, and visual outcome in patients with non-contact lens related Acanthamoebakeratitis and compare the findings with reported series of contact lens ...

NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the Food and Drug ...